← Back to headlines
AbbVie signs pain drug licensing deal with China’s Haisco
Pharmaceutical giant AbbVie has entered into a licensing agreement with China's Haisco for a pain drug, expanding its presence in the Chinese market.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Genetically Modified Pig Kidney Sustains Patient for Record Nine Months
28m ago
UNICEF Report Finds 20 Million Children Annually Face Online Sexual Exploitation
1h ago
Pentagon Temporarily Rescinds Testosterone Screening Guidance for Troops
4h ago
RFK Jr. Allegedly Requested Removal of Measles Deaths From CDC Tally
5h ago